The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunogenicity of pembrolizumab (pembro) in patients (pts) with advanced melanoma (MEL) and non-small cell lung cancer (NSCLC): Pooled results from KEYNOTE-001, 002, 006, and 010.
 
Marianne van Vugt
Employment - Merck
 
Rik de Greef
Employment - Merck
 
Tomoko Freshwater
Employment - Merck
 
Eric Mangin
Employment - Merck
 
Frank van Aarle
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Anna Kondic
Employment - Merck